Lars Wesslén

1.1k total citations
35 papers, 787 citations indexed

About

Lars Wesslén is a scholar working on Cardiology and Cardiovascular Medicine, Parasitology and Infectious Diseases. According to data from OpenAlex, Lars Wesslén has authored 35 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 13 papers in Parasitology and 10 papers in Infectious Diseases. Recurrent topics in Lars Wesslén's work include Viral Infections and Immunology Research (13 papers), Cardiovascular Effects of Exercise (11 papers) and Vector-borne infectious diseases (8 papers). Lars Wesslén is often cited by papers focused on Viral Infections and Immunology Research (13 papers), Cardiovascular Effects of Exercise (11 papers) and Vector-borne infectious diseases (8 papers). Lars Wesslén collaborates with scholars based in Sweden, Denmark and Norway. Lars Wesslén's co-authors include Göran Friman, Jan Fohlman, G Friman, Nils‐Gunnar Ilbäck, Jouko Karjalainen, Ulf Lindh, Eva Hjelm, Martin Holmberg, Christer Rolf and Kåre Bondeson and has published in prestigious journals such as The Lancet, The Science of The Total Environment and Journal of Clinical Microbiology.

In The Last Decade

Lars Wesslén

35 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Wesslén Sweden 17 343 226 173 133 87 35 787
Giustina Vitale Italy 18 99 0.3× 212 0.9× 300 1.7× 242 1.8× 11 0.1× 30 903
Michael D. Willard United States 21 28 0.1× 142 0.6× 76 0.4× 119 0.9× 16 0.2× 37 1.1k
Eran Dvir South Africa 17 102 0.3× 175 0.8× 160 0.9× 52 0.4× 7 0.1× 42 810
K. Vörös Hungary 15 95 0.3× 96 0.4× 126 0.7× 63 0.5× 26 0.3× 45 556
Olle Lindquist Sweden 19 191 0.6× 391 1.7× 452 2.6× 128 1.0× 2 0.0× 50 1.3k
Paul Hshieh United States 16 143 0.4× 150 0.7× 30 0.2× 155 1.2× 74 0.9× 23 987
Daniel C. McGillicuddy United States 16 74 0.2× 84 0.4× 40 0.2× 125 0.9× 11 0.1× 31 793
Kent A. Gossett United States 17 44 0.1× 39 0.2× 75 0.4× 129 1.0× 12 0.1× 46 770
Pentti I. Halonen Finland 12 248 0.7× 75 0.3× 53 0.3× 149 1.1× 8 0.1× 39 674
D P Kotler United States 15 21 0.1× 203 0.9× 415 2.4× 311 2.3× 5 0.1× 18 1.2k

Countries citing papers authored by Lars Wesslén

Since Specialization
Citations

This map shows the geographic impact of Lars Wesslén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wesslén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wesslén more than expected).

Fields of papers citing papers by Lars Wesslén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Wesslén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wesslén. The network helps show where Lars Wesslén may publish in the future.

Co-authorship network of co-authors of Lars Wesslén

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Wesslén. A scholar is included among the top collaborators of Lars Wesslén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Wesslén. Lars Wesslén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Palanisamy, Navaneethan, et al.. (2013). Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a. Antiviral Research. 99(1). 12–17. 54 indexed citations
3.
Wesslén, Lars, et al.. (2005). Bartonella spp. seroprevalence in healthy Swedish blood donors. Scandinavian Journal of Infectious Diseases. 37(10). 723–730. 37 indexed citations
4.
Jensenius, Mogens, Pierre‐Edouard Fournier, Lars Wesslén, et al.. (2003). Sequential changes in hematologic and biochemical parameters in African tick bite fever. Clinical Microbiology and Infection. 9(7). 678–683. 12 indexed citations
5.
Jonason, Tommy, et al.. (2003). Left ventricular volume changes during supine exercise in young endurance athletes. Acta Physiologica Scandinavica. 177(4). 467–472. 7 indexed citations
6.
Wesslén, Lars, et al.. (2002). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on trace elements, inflammation and viral clearance in the myocardium during Coxsackievirus B3 infection in mice. The Science of The Total Environment. 284(1-3). 135–147. 20 indexed citations
7.
Henriksen, Egil, Tommy Jonason, Lars Wesslén, et al.. (2001). Thallium-201 Myocardial Imaging at Rest in Male Orienteers and Other Endurance Athletes. Upsala Journal of Medical Sciences. 106(1). 59–66. 2 indexed citations
8.
Lannergård, Anders, Jan Fohlman, Lars Wesslén, Christer Rolf, & G Friman. (2001). Immune function in Swedish élite orienteers. Scandinavian Journal of Medicine and Science in Sports. 11(5). 274–279. 3 indexed citations
9.
Lindh, Ulf, et al.. (2000). Trace element changes in the myocardium in relation to inflammation and viral clearance during coxsackievirus B3 myocarditis in the mouse. Biological Trace Element Research. 75. 0. 2 indexed citations
10.
Friman, Göran & Lars Wesslén. (2000). Special feature. Infections and exercise in high-performance athletes.. Immunology and Cell Biology. 78. 0. 1 indexed citations
11.
Ilbäck, Nils‐Gunnar, Ulf Lindh, Lars Wesslén, Jan Fohlman, & Göran Friman. (2000). Trace Element Distribution in Heart Tissue Sections Studied by Nuclear Microscopy Is Changed in Coxsackie Virus B3 Myocarditis in Methyl Mercury-Exposed Mice. Biological Trace Element Research. 78(1-3). 131–148. 26 indexed citations
12.
Lindh, Ulf, et al.. (2000). Trace Element Changes in the Myocardium During Coxsackievirus B3 Myocarditis in the Mouse. Biological Trace Element Research. 76(2). 149–160. 20 indexed citations
13.
Holmberg, Martin, Stuart M. McGill, Lars Wesslén, et al.. (1999). Evaluation of Human Seroreactivity to Bartonella Species in Sweden. Journal of Clinical Microbiology. 37(5). 1381–1384. 30 indexed citations
14.
Larsson, Erik, et al.. (1999). Sudden unexpected cardiac deaths among young Swedish orienteers — Morphological changes in hearts and other organs. Apmis. 107(1-6). 325–336. 29 indexed citations
15.
Henriksen, Egil, J Landelius, Lars Wesslén, et al.. (1997). An Echocardiographic Study Comparing Male Swedish Elite Orienteers With Other Elite Endurance Athletes. The American Journal of Cardiology. 79(4). 521–524. 3 indexed citations
16.
Blomqvist, Gunilla, Lars Wesslén, Carl Påhlson, et al.. (1997). Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsis. Journal of Clinical Microbiology. 35(8). 1988–1995. 15 indexed citations
17.
Ilbäck, Nils‐Gunnar, Lars Wesslén, Jan Fohlman, & Göran Friman. (1996). Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (Coxsackie B3 myocarditis). Toxicology Letters. 89(1). 19–28. 45 indexed citations
18.
Wesslén, Lars, Olle Lindquist, Eva Hjelm, et al.. (1996). An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. European Heart Journal. 17(6). 902–910. 92 indexed citations
19.
Henriksen, Egil, J Landelius, Lars Wesslén, et al.. (1996). Echocardiographic right and left ventricular measurements in male elite endurance athletes. European Heart Journal. 17(7). 1121–1128. 56 indexed citations
20.
Friman, G, et al.. (1995). The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy. European Heart Journal. 16(suppl O). 36–41. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026